Abstract
During the last five years, there has been a striking change in the early management of acute myocardial infarction. This results from several hemodynamic investigations that clearly established that thrombosis [1–2] plays a major role in this disease. Both early and late mortality of patients after myocardial infarction is mainly related to the degree of dysfunction of the left ventricle, which in turn depends on the size of the initial infarct. Therefore, it has been attempted to obtain immediate reperfusion of the infarction myocardium. Immediate thrombolytic therapy is a rational mean of achieving early reperfusion. Several thrombolytic agents are now available and can be administered by either the intracoronary or intravenous routes. However, after successful thrombolysis residual high-grade obstruction often persists at the site of the previous occlusion and could be responsible for continued myocardial ischemia and/or reocclusion. Therefore, percutaneous transluminal coronary angioplasty (PTCA) was proposed after successful thrombolysis. Later on, the ability to perform this technique in patients with acute myocardial infarction led several investigators to try percutaneous transluminal coronary angioplasty as the primary approach to reperfusion of the myocardium. Thus, we will address the problem of PTCA preceded by thrombolysis and primary PTCA in patients with acute myocardial infarction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, Lang HT: Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303: 897, 1980.
DeWood MA, Spores J, Henslly GR, Simpson CS, Engster GS et al.: Coronary arteriographie findings in acute transmural myocardial infarction. Circulation 68: 39, 1983.
Serruys PW, Van Den Brand M, Hooghoudt TEH, Simmons ML, Fioretti P, Ruiter J, Fels PW, Hugenholtz PG: Coronary recanalization in acute myocardial infarction: Immediate results and potential risks Eur Heart J 3: 404, 1982.
Gold HK, Cowley MJ, Palacios IF, et al.: Combined intracoronary streptokinase infusion and coronary angioplasty during acute myocardial infarction. Am J Cardiol 53: 122, 1984.
Cribier A, Berland J, Champoud B, Moore N, Behar P, Letac B: Intracoronary thrombolysis in evolving myocardial infarction. Br Heart J 50: 401, 1983.
Kennedy JW, Ritchie JL, Davis KB, Fritz JK: Western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. N Engl J Med 309: 1477, 1983.
Ferguson DW, White CW, Schwartz JL, Brayden GP, Kelly KJ, et al.: Influence of baseline ejection fraction and success of thrombolysis on mortality and ventricular function after acute myocardial infarction. Am J Cardiol 54: 705, 1984.
Leiboff RH, Katz RJ, Wasserman AG, Bren GB, Schwartz H, Verghese PJ, Ross AM: A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction. Am J Cardiol 53: 404, 1984.
Rentrop KP, Feit F, Blanke H, Stecy P, Schneider R, Rey M, Horowitz S, Goldman M, Karsch K, Meilman H, Cohen M, Siegel S, Sanger J, Slater J, Gorlin R, Fox A, Fagerstrom R, Calhoun WF: Effects of intracoronary streptokinase and intracoronary nitroglycerine infusion on coronary angiographie patterns and mortality in patients with acute myocardial infarction. N Engl J Med 311: 1464, 1984.
Mathey DG, Kuck KH, Tilsner V, Krebber HJ, Bleifeld W: Non-surgical coronary artery recanalization in acute transmural myocardial infarction. Circulation 63: 489, 1981.
Rentrop P, Blanke H, Karsch KR, Kaiser H, Kostering H, Leitz K: Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris. Circulation 63: 307, 1981.
Meyer J, Merx W, Dorr R, Lambertz H, Bethge CH, Effaert S: Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recalanlization (PTCR) and percutaneous transluminal coronary angioplasty (PTCA). Am Heart J 1: 132, 1982.
Meyer J, Merx W, Schweitzer P: Advantages of combining transluminal coronary angioplasty (PTCA) with selective coronary thrombolysis in acute infarction (abstract). Circulation 66(Suppl II): 262, 1982.
Meyer J, Merx W, Schmitz H, Erber R, Kiesslich T, Dor R, Lambertz H, Bethge C, Krebs W, Bardos P, Minale MC, Messmer BJ, Effect J: Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction. Circulation 66: 905, 1982.
Gold HK, Cowley MJ, Palacios IF, Vetrovec GW, Akins CW, Block PC, Leinbach RC: Combined intracoronary streptokinase infusion and coronary angioplasty during acute myocardial infarction. Am J Cardiol 53: 122C, 1984.
Valeix B, Labrunie P, Puel J, Bertrand ME, Guarino L, Monassier JP, Vilarem D, Lablanche JM, Morand PH, Bounhoure JP, Levy S, Gerard R: L’angioplastie coronarienne immédiatement après thrombolyse intracoronarienne en phase aigue d’infarctus du myocarde. Arch Mal Coeur 77: 1315, 1984.
Erbel R, Pop T, Hentkel B, Schieiner G, Rupprecht HJ, Henrichs KJ, Meyer J: Immediate angioplasty after reperfusion in acute myocardial infarction. A prospective controlled randomized trial. Circulation 72(Suppl III): 223, 1985.
Harrison DG, Ferguson DW, Collins SM, et al.: Rethrombosis after reperfusion with streptokinase: Importance of geometry of residual lesions. Circulation 69: 991, 1984.
Cribier A, Berland J, Saoudi N, Letac B: Sequential quantification of coronary stenosis 10 days and 3 months after coronary revascularization in acute myocardial infarction. Eur Heart J 5: 762, 1984.
Serruys PW, Wijns W, Van Den Brad M, Ribeiro V, Fioretti P, Simoons ML, Kooijman CJ, Reiber JH, Hugenholtz P: Is transluminal angioplasty mandatory after successful thrombolysis? Quantitative coronary angiographic study. Br Heart J 50: 257, 1983.
Gruppo Italiano per lo studio della streptokinase nell infarcto miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1: 397, 1986.
ISIS-2 (second international study of infarct survival) collaborative group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17, 187 cases of suspected acute myocardial infarction. Lancet 2: 346, 1988.
The ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM): Mortality, morbidity, and infarct size at 21 days. N Engl J Med 314: 1465, 1986.
AIMS Trial Study Group: Effect of intravenous APS AC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1: 545, 1988.
Topol EJ, Califf RM, George BS, et al. A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction. N Engl J Med 317: 581, 1987.
Simoons ML, Arnold AER, Betriu A, et al. Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty. Lancet 1: 197, 1988.
The TIMI Research Group. Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction: TIMI IIA results. JAMA 260:2849, 1988.
The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) Phase II Trial. N Engl J Med 320: 618, 1989.
Hartzler G, Rutherford B, MacConahay D: Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction. Am Heart J 106: 965, 1983.
Hartzler G, Rutherford B, MacConahay D: Percutaneous coronary angioplasty with and without prior streptokinase infusion for treatment of acute myocardial infarction. Am J Cardiol 53: 117C, 1984.
Papapietro SE, McLean WA, Stanley AW, Randall G, Corley D, Arciniegas J, Cooper TB: Percutaneous transluminal coronary angioplasty after intracoronary streptokinase in evolving acute myocardial infarction. Am J Cardiol 55: 48, 1985.
Roger WJ, Mantle JA, Hood WP, Boxley WA, Whitlow PI, Reeves RC, Soto B: Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction. Circulation 68: 1051, 1983.
Saltups A, Boxal J, Ho B: Intracoronary versus intravenous streptokinase in acute myocardial infarction. Circulation 68(Suppl III): 119, 1983.
Schroeder R, Biamino G, Von Leitner ER, Linderer T, Brueggemann T, Heitz J, Voehringer HF, Wegscheider K: Intravenous short-term infusion of streptokinase in acute myocardial infarction. Circulation 67: 536, 1983.
Alderman EL, Jutzy KR, Berte LE, Miller RG, Friedman JP, Creger WP, Eliastam M: Randomized comparison for intravenous versus intracoronary streptokinase for myocardial infarction. Am Cardiol 54: 14, 1984.
Spann JE, Sherry S, Carabello BA, Denenberg BS, Mann RH, McCann WD, Gault JH, Gentzler RD, Belber AD, Maurer AH, Cooper EM: Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow up studies. Am Cardiol 53: 655, 1984.
Ganz W, Geft I, Shah PK, Lew AS, Rodriguez L, Weiss T, Macdahi J, Berman DS, Charuzi Y, Swan HJC: Intravenous streptokinase in evolving acute myocardial infarcton. Am J Cardiol 53: 1209, 1984.
Olson HG, Lyons KP, Butman S, Piters KM, Gardin JM: A randomized controlled trial of intravenous streptokinase in acute myocardial infarction. Circulation 70(Suppl II): II155, 1984.
Anderson JL, Marshall HW, Askins JC, Lutz JR, Sorensen SG, Menlove RL, Yanowitz FG, Hagan AD: A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction. Circulation 70: 606, 1984.
Taylor GJ, Mikell FL, Moses HW, Dove JT, Batchelder JE, Thull A, Hansen S, Wellons HA, Schneider J: Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitals. Am J Cardiol 54: 256, 1984.
Chesebro JA, Smith HC, Holmes DR, Bove AA, Bresnahan DR, Bresnahan JF, Gibbons RJ, et al.: Reocclusion and clot lysis between 90 minutes, 1 day and 10 days after thrombolytic therapy for myocardial infarction. Circulation 72(Suppl III): 55, 1985.
Bassand JP, Faivre R, Habert C, Becque O, Peliteau JL, Maurat JP: Intravenous streptokinase versus heparin in evolving myocardial infarction: A randomized trial. Circulation 72: 223, 1985.
TIMI study group: The thrombolysis in myocardial infarction trial. N Engl J Med 31: 932, 1985.
Erbel R: Randomized trial of intravenous tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Circulation 72(Suppl III): 223, 1985.
Topol EJ, Ciuffo AA, Pearson TA, et al.: Thromnbolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion. J Am Coll Cardiol 5: 85, 1985.
Rutherford B, Hartzler GO, McConahay DR, Johnson WL: Direct balloon angioplasty in acute myocardial infarction without prior use of streptokinase. J Am Coll Cardiol 7: 149A, 1986.
Pepine CJ, Prida X, Hill JA, Feldman CL, Conti CR: Percutaneous transluminal coronary angioplasty in acute myocardial infarction Am Heart J 107: 820, 1984.
Valeix B, Labrunie P, Marco J, Puel J, Bory M, Sainsous J, Monassier JP, Heitz A, Gaspard Ph, Guraino L, Machecourt J, Koening M, Levy S, Gerard R: L’angioplastie coronaire d’emblée en phase aigue d’infarctus du myocarde. Etude multicentrique française. Arch Mal Coeur 78: 831, 1985.
Levy S, Gerard R: L’angioplastie coronaire d’emblée en phase aigue d’infarctus du myocarde, Etude multicentrique française. Arch. Mal. Coeur 78: 831, 1985.
Caster L, Marco J, Eajadet J, Bernis JP, Bernardet P: Desobstruction coronarienne par angioplastie transluminale à la phase aigue de l’infarctus du myocarde. Arch Mal Coeur, in press.
Kalbfleisch J, Friedman M, Slagle R, et al.: A randomized trial of immediate coronary angioplasty following intracoronary thrombolysis in acute myocardial infarction (abstract). J Am Coll Cardiol 3: 574, 1984.
Holmes DR, Nishimura RA, Vlietstra RE, et al.: Percutaneous transluminal coronary angioplasty (PTCA) during evolving acute myocardial infarction (abstract). J Am Coll Cardiol 3: 575, 1984.
O’Neill WW, Lai PY, Ganadharon V, et al.: Preliminary report of a randomized, prospective clinical trial of intracoronary streptokinase versus coronary angioplasty therapy of acute myocardial infarction (abstract). J Am Coll Cardiol 5: 494, 1985.
Rothbaum DA, Linnemeier TJ, Noble J: Emergency percutaneous transluminal angiplasty in acute myocardial infarction. J Am Coll Cardiol 7: 149A, 1986.
Kander N, O’Neill W, Topol E, Walton JA, Bourdillon PD, Bates E, Kryski T, Pitt B: Prognosis after acute coronary angioplasty therapy of acute myocardial infarction. J Am Coll Cardiol 7: 150A, 1986.
Arie S, Bellotti G, Checchi H, Alves L, Ramires JA, Pileggi F: Transluminal coronary angioplasty in the acute infarct related artery: Short and long term results J Am Coll Cardiol 7: 150 A, 1986.
O’Neill WW, Erbel R, Laufer N, et al.: Coronary angioplasty therapy of cardiogenic shock complicating acute myocardial infarction (abstract). Circulation 72: III–309, 1985.
Lee L, Walton JA, Bates E, et al.: Cardiogenic shock complicating acute myocardial infarction: Changing therapies and prognosis circulation (abstract). Circulation 74: II–276, 1986.
Shani J, Rivera M, Greengart A, et al.: Percutaneous transluminal coronary angioplasty in cardiogenic shock (abstract). J Am Coll Cardiol 7: 149A, 1986.
Heuser RR, Maddoux GL, Goss JE, et al.: Coronary angioplasty in the treatment of cardiogenic shock: The therapy of choice. J Am Coll Cardiol 7: 219A, 1986.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bertrand, M.E., Lablanche, J.M., Fourrier, J.L., Gommeaux, A. (1989). Percutaneous Transluminal Coronary Angioplasty in Acute Myocardial Infarction. In: Rapaport, E. (eds) Early Interventions in Acute Myocardial Infarction. Developments in Cardiovascular Medicine, vol 97. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1597-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1597-1_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8884-8
Online ISBN: 978-1-4613-1597-1
eBook Packages: Springer Book Archive